Key result
Cryo-EM structures of the human Mas receptor reveal that its own N-terminal peptide occludes the orthosteric binding pocket as an endogenous pseudo-ligand, establishing a structural framework.
Why the study?
Despite its physiological importance in the renin-angiotensin system and cardiovascular disease, the structural basis of MasR has remained unknown.
The first cryo-EM structures of the human Mas receptor reveal an N-terminal occlusion of the orthosteric binding pocket, providing a structural template for future drug design.
No change to clinical RAS modulation; leaves open structure-based design of MasR Gq modulators across Mrgpr subfamily.
• Cryo-EM structures of human MasR in complex with heterotrimeric Gq are determined at 2.89 Å and 3.08 Å resolution. • The receptor’s own N-terminal peptide (residues 2–11) occludes the orthosteric binding pocket as an endogenous pseudo-ligand. • N-terminal pocket occlusion is structurally stable but dispensable for constitutive Gq coupling. • A conserved Gq-coupling interface at ICL2 is shared across the Mrgpr receptor subfamily. The Mas receptor (MasR) is a class A G protein-coupled receptor (GPCR) that mediates the counter-regulatory arm of the renin–angiotensin system through the ACE2–angiotensin-(1-7)–MasR axis and represents a promising therapeutic target for cardiovascular and metabolic disease. Despite its physiological importance, the structural basis of MasR has remained unknown. Here we report cryo-EM structures of human MasR in complex with heterotrimeric Gq at resolutions of 2.9 Å and 3.1 Å, determined for the full-length receptor and an N-terminally truncated variant (del2-25), respectively. These structures reveal that the receptor’s own N-terminal peptide (residues 2–11) threads into and occludes the orthosteric binding pocket, functioning as an endogenous pseudo ligand. Functional mutagenesis and molecular dynamics simulations demonstrate that this N-terminal cap stably occupies the pocket but is dispensable for constitutive Gq coupling, distinguishing MasR from other N-terminal cap-forming GPCRs. Structural comparison with Mrgpr family members reveals a conserved Gq-coupling interface at the cytoplasmic face alongside divergent extracellular pocket architectures and identifies Y252 6.59 as a structural element that occludes a conserved sub-pocket present in Mrgpr paralogs. Molecular docking simulation of the MasR agonist AR234960 provides a structural template for orthosteric ligand design. Together, these findings establish the structural framework for MasR.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied Cardiovascular and metabolic disease. Cryo-EM structures of the human Mas receptor reveal that its own N-terminal peptide occludes the orthosteric binding pocket as an endogenous pseudo-ligand, establishing a structural framework.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: